EMA — authorised 22 August 2007
- Application: EMEA/H/C/000852
- Marketing authorisation holder: Novartis Europharm Ltd.
- Local brand name: Tekturna
- Indication: Treatment of essential hypertension
- Status: withdrawn
🇪🇺 Aliskiren 150 mg in European Union
EMA authorised Aliskiren 150 mg on 22 August 2007
Marketing authorisation
Aliskiren 150 mg in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Aliskiren 150 mg approved in European Union?
Yes. EMA authorised it on 22 August 2007.
Who is the marketing authorisation holder for Aliskiren 150 mg in European Union?
Novartis Europharm Ltd. holds the EU marketing authorisation.